DUBLIN, March 11, 2020 /PRNewswire/ -- The "Cell Therapy Market Size, Share & Trends Analysis Report by Use-type (Research, Commercialized, Musculoskeletal Disorders), by Therapy Type (Autologous, Allogeneic), by Region, and Segment Forecasts, 2020 - 2027" report has been added to ResearchAndMarkets.com's offering.
The global cell therapy market size is expected to reach USD 8.8 billion by 2027 at a CAGR of 5.4%, over the forecast period.
Cellular therapies hold a great therapeutic promise across various clinical applications. This has resulted in substantial global investments in research and clinical translation. Moreover, rapid advances in stem cell research hold the potential to fulfill the unmet demand of pharmaceutical entities, biotech entities, and doctors in disease management. These factors have boosted revenue growth for the market.
Currently, there are a limited number of FDA-approved commercial stem and non-stem cell therapies in the market. Furthermore, LAVIV (Azficel-T), manufactured and commercialized by Fibrocell Technologies, witnessed revenue wind-down in the past years. Key developers are making substantial investments in the adoption of advanced technologies to address the aforementioned challenges.
The introduction of proprietary cell lines is recognized as the primary means by which a single cell can be exploited for the production of a robust portfolio of candidates. Companies are leveraging new technologies not only for the expansion of their product portfolio but also for establishing out-licensing or co-development agreements with other entities to support their product development programs.
For instance, MaxCyte has more than 40 high-value cellular therapy partnership programs within immune-oncology, regenerative medicine, and gene editing, including fifteen clinical-stage programs. Increase in the number of collaborations between entities for product commercialization is anticipated to accelerate market revenue to a major extent in the coming years.
In Asia-Pacific, the market is anticipated to witness significant growth over the forecast period. This is attributed to rising awareness cellular therapies among patients and healthcare entities in chronic disease management. In addition, availability of therapeutic treatment at lower prices is also driving the regional market. Japan is likely to witness fast growth over the forecast period attributed to increasing research activities on regenerative medicine.
Further key findings from the report suggest:
Key Topics Covered
Chapter 1 Executive Summary
Chapter 2 Research Methodology
Chapter 3 Cell Therapy Market Variables, Trends & Scope3.1 Market Segmentation & Scope3.1.1 Market driver analysis3.1.1.1 Rise in number of clinical studies pertaining to the development of cellular therapies3.1.1.2 Rising adoption of regenerative medicine3.1.1.3 Introduction of novel platforms and technologies3.1.2 Market restraint analysis3.1.2.1 Ethical concerns related to stem cell research3.1.2.2 Clinical issues pertaining to development & implementation of cell therapy3.1.2.2.1 Manufacturing issues3.1.2.2.2 Genetic instability3.1.2.2.3 Stem cell culture condition3.1.2.2.4 Stem cell distribution after transplant3.1.2.2.5 Immunological rejection3.1.2.2.6 Challenges associated with allogeneic mode of transplantation3.2 Penetration & Growth Prospect Mapping For Therapy Type, 20193.3 Cell Therapy Market (Stem & Non-stem Cells)-Swot Analysis, by Factor (Political & Legal, Economic and Technological)3.4 Industry Analysis - Porter's3.5 Cell Therapy Market (Stem & Non-stem Cells)-Regulatory Landscape
Chapter 4 Cell Therapy Market (Stem & Non-stem Cells) Categorization: Use-type Estimates & Trend Analysis4.1 Cell Therapy Market (Stem & Non-stem Cells): Use-type Movement Analysis4.2 Clinical-use4.3 Research-use
Chapter 5 Cell Therapy Market (Stem & Non-stem Cells) Categorization: Therapy Type Estimates & Trend Analysis5.1 Cell Therapy Market (Stem & Non-stem Cells): Therapy Type Movement Analysis5.2 Allogeneic Therapies5.3 Autologous Therapies
Chapter 6 Cell Therapy Market (Stem & Non-stem Cells) Categorization: Regional Estimates & Trend Analysis, by Product6.1 Cell Therapy Market (Stem & Non-stem Cells) Share by Regional, 2019 & 20276.2 North America6.3 Europe6.4 Asia-Pacific6.5 Latin America6.6 MEA
Chapter 7 Competitive Landscape7.1 Strategy Framework7.2 Company Profiles7.2.1 Kolon TissueGene, Inc.7.2.2 JCR Pharmaceuticals Co. Ltd.7.2.3 MEDIPOST7.2.4 Osiris Therapeutics, Inc.7.2.5 Stemedica Cell Technologies, Inc.7.2.6 Cells for Cells7.2.7 NuVasive, Inc.7.2.8 Fibrocell Science, Inc.7.2.9 Vericel Corporation7.2.10 Pharmicell Co. Ltd.7.2.11 Anterogen Co. Ltd.7.2.12 Celgene Corporation
For more information about this report visit https://www.researchandmarkets.com/r/ma559h
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.
Media Contact:
Research and Markets Laura Wood, Senior Manager press@researchandmarkets.com
For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1904 Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets
- The Science Of Health: Are Spinal Cord Injuries Irreversible? Know Science Advances That Can Cure Them In The Future - ABP Live - October 16th, 2023
- Biden Weaponized Health Care on Abortion, Transgender, COVID-19 - Daily Signal - April 23rd, 2023
- Can This Company's Research Help Transform Regenerative Medicine As Its Lead Product Receives FDA IND Approval? - Marketscreener.com - November 17th, 2022
- BIOADAPTIVES, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q) - Marketscreener.com - November 17th, 2022
- With fewer inmates (and officers), Michigan closes another prison - Bridge Michigan - September 12th, 2022
- Testol 140 Review, Real Testol-140 Reviews Before and After Results - Dailyuw - September 12th, 2022
- Can California deliver on its zero-emission car goal? - Los Angeles Times - September 12th, 2022
- Researchers revive abandoned technique in effort to make artificial human eggs in a test tube - STAT - August 3rd, 2022
- 'Incredibly prejudicial': Why Sacramento courts have caged cells, and why that'll change - Walla Walla Union-Bulletin - August 3rd, 2022
- Ethical Issues in Stem Cell Research - PubMed Central (PMC) - December 22nd, 2021
- Dream Body Clinic Stem Cell Therapy Stem Cells HGH - December 22nd, 2021
- Stem cells | healthdirect - December 22nd, 2021
- Human Embryonic Stem Cells | The Embryo Project Encyclopedia - December 22nd, 2021
- Stem cells, through a religious lens Harvard Gazette - December 22nd, 2021
- Scientists identify 2nd HIV patient whose body rid itself of virus - National Herald - November 21st, 2021
- Need to streamline research on CRISPR gene-editing technology: Experts - Business Standard - November 21st, 2021
- Atrial Fibrillation Market Growth Driven by Technological Advancements in AFib Systems and Solutions and Rapidly Increasing Geriatric Population -... - November 21st, 2021
- Could Regenerative Biology Work in Humans? - Harvard Magazine - July 21st, 2021
- Alberta and NWT Bishops OK vaccination for COVID Grandin Media - Grandin Media - December 3rd, 2020
- The way prisoners flag guard abuse, inadequate health care and unsanitary conditions Is broken - injusticewatch.org - December 3rd, 2020
- From Roaches To Medical Emergencies, Illinois Inmates Say Theres Nobody That We Can Really Go To For Help - WBEZ - December 3rd, 2020
- Alexion Receives Marketing Authorization from European Commission for New Formulation of ULTOMIRIS (ravulizumab) with Significantly Reduced Infusion... - November 20th, 2020
- California's Stem Cell Agency Will Get A Funding Boost From Prop 14. Here's A Look At Its History. - Capital Public Radio News - November 19th, 2020
- Stem Cell Banking Market is Projected to Reach $6,956 million by 2023 | Leading key players are Cord Blood Registry, ViaCord, Cryo-Cell, China Cord... - November 19th, 2020
- Locked up during the Waupun COVID surge - Wisconsin Examiner - November 19th, 2020
- Panelists debate the implications and ethics of stem cell research - Johns Hopkins News-Letter - November 2nd, 2020
- Rapid Reshore & Development and BrainStorm Cell Therapeutics Announce Agreement to Advance Construction of BrainStorm's US Manufacturing Facility... - November 2nd, 2020
- Is the Pro-Life Movement on a Collision Course with the Coronavirus? - The Dispatch - November 2nd, 2020
- Will Trevor Lawrence stay at Clemson to avoid the Jets? - Yahoo! Voices - November 2nd, 2020
- Spurs' Becky Hammon honored with impressive San Antonio mural - Yahoo! Voices - November 2nd, 2020
- Total Student Enrollment of China New Higher Education Group Achieves Strong Organic Growth to a New Record High -- Total Number of Enrolled Students... - November 2nd, 2020
- Elis announces the acquisition of 3 laundries in Brazil - Yahoo Finance UK - November 2nd, 2020
- Stem Cell Banking Market is forecast to reach $6,956 million by 2023 | ViaCord,Cryo-Cell, China Cord Blood Corporation, Cryo-Save - The Daily... - October 2nd, 2020
- Those linked to stem cell board received more than $2.1 billion - Capitol Weekly - September 16th, 2020
- Patenting Stem Cell Inventions in India- What to Expect? - Lexology - September 13th, 2020
- Global Stem Cell Banking Market Is Projected To Witness Vigorous Expansion By 2026 - Kewaskum Statesman News Journal - September 13th, 2020
- How Close Are We To Making Babies from Bone Marrow? - Discover Magazine - August 12th, 2020
- India could bleed itself dry amidst covid-19 crisis owing to blood shortage - ETHealthworld.com - July 12th, 2020
- Court rules controversial stem cell research is legal - July 10th, 2020
- Legal Issues in Stem Cell Therapy in the U.S. - Inventus Law - June 19th, 2020
- Restoring vision to the blind - Science Magazine - May 22nd, 2020
- Death of a Survivor - The New Republic - May 4th, 2020
- Could Cannabis Be an Effective Treatment for COVID-19? - Lab Manager Magazine - April 29th, 2020
- The Republicans who were once so pro-life they fought over one woman on life support now want to sacrifice grandma for the economy - The Independent - April 29th, 2020
- Russia's Humanitarian Law Obligations to Civilians in Occupied Ukrainian Territories in the Time of COVID-19 - Just Security - April 29th, 2020
- Merck Boosts Commercial Viral Vector and Gene Therapy Manufacturing Capacity - PR Newswire UK - April 22nd, 2020
- The tragic life of Meredith Vieira - Nicki Swift - March 17th, 2020
- The 411 on Stem Cells: What They Are and Why It's Important to Be Educated - Legal Examiner - February 20th, 2020
- The Challenge of Bioethics to Decision-Making in the UK - Westminster Abbey - February 20th, 2020
- Penn announces seven 2020 Thouron Award winners - Penn: Office of University Communications - February 20th, 2020
- BrainStorm Cell Therapeutics to Present at the 2020 Biotech Showcase and 3rd Annual Neuroscience Innovation Forum at JPM Week - GlobeNewswire - January 7th, 2020
- Drugs, Biologics, and Regenerative Medicine in 2019: A Successful Year Ends with Promise of a More Challenging 2020 - JD Supra - December 21st, 2019
- Edited Transcript of MRKR.OQ earnings conference call or presentation 12-Nov-19 10:00pm GMT - Yahoo Finance - November 29th, 2019
- BrainStorm Announces Financial Results for the Third Quarter of 2019 and Provides a Corporate Update - GlobeNewswire - November 19th, 2019
- What to Know in Washington: Trump Ally in Impeachment Spotlight - Bloomberg Government - November 19th, 2019
- Do transhumanists need their own bill of rights? - Quartz - October 27th, 2019
- Does Stem Cell Therapy Work For Back Pain? - Regenexx - October 8th, 2019
- The Ethical, Social & Legal Issues of Cloning Animals ... - October 8th, 2019
- An Overview of Stem Cell Research | The Center for ... - October 5th, 2019
- Ethical Issues in Stem Cell Research | Endocrine Reviews ... - October 2nd, 2019
- Embryo - Wikipedia - October 2nd, 2019
- Legal Issues in Stem Cell Therapy in the U.S. - Royse Law Firm - September 14th, 2019
- Research With Stem Cells | American Medical Association - May 23rd, 2019
- Practical Problems with Embryonic Stem Cells - usccb.org - March 17th, 2019
- Stem Cells For Dummies: The Controvery, Pros and Cons ... - March 6th, 2019
- Human cloning - Wikipedia - February 18th, 2019
- stem cell | Definition, Types, Uses, Research, & Facts ... - December 12th, 2018
- Timeline of major events in stem cell research policy ... - August 25th, 2018
- stem-cells | ETHICAL, LEGAL, AND SOCIAL ISSUES - July 29th, 2018
- The Legal and Ethical Issues of Cloning That Make it ... - October 11th, 2017
- 5 Ethical and Legal Issues | Cord Blood: Establishing a ... - September 21st, 2017
- FDA Grants Orphan Drug Status to Cellect's ApoGraft for Acute GvHD and Chronic GvHD - PR Newswire (press release) - September 5th, 2017
- Of cell phones and swords things Amarilloans should know about new state laws - Amarillo.com - September 1st, 2017
- Cellect Shares Will Be Traded From Next Week Exclusively on NASDAQ - PR Newswire (press release) - September 1st, 2017
- ICMR to release stem cell research guidelines soon - BSI bureau (press release) - September 1st, 2017
- ICMR's stem cell research guidelines soon to be released - ETHealthworld.com - August 31st, 2017
- Should your medical data be off the record? - The Irish Times - Irish Times - August 25th, 2017
- Combatting the spread of anti-vaccination sentiment - OUPblog (blog) - August 25th, 2017
- Embryonic stem cell - Wikipedia - August 24th, 2017
- How processing health data has become increasingly problematic - Irish Times - August 24th, 2017